Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV004791192 | SCV005413406 | pathogenic | not provided | 2024-04-08 | criteria provided, single submitter | clinical testing | PM2_moderate, PM3, PVS1 |
Gene |
RCV004791192 | SCV005419409 | likely pathogenic | not provided | 2024-12-09 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 32581362, 25156943, 19377077, 29895660, 18596229, 24382527, 21783390) |
Labcorp Genetics |
RCV004791192 | SCV005840364 | pathogenic | not provided | 2024-08-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg599*) in the TMPRSS6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TMPRSS6 are known to be pathogenic (PMID: 20232450, 25156943). This variant is present in population databases (rs137853123, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with TMPRSS6-related conditions (PMID: 18596229, 32581362). ClinVar contains an entry for this variant (Variation ID: 1408). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV001375844 | SCV000021628 | pathogenic | Iron-refractory iron deficiency anemia | 2008-09-01 | no assertion criteria provided | literature only | |
NIHR Bioresource Rare Diseases, |
RCV000001473 | SCV001162263 | likely pathogenic | Microcytic anemia | no assertion criteria provided | research |